Manufacturing - Tools & Accessories
Compare Stocks
5 / 10Stock Comparison
LECO vs PH vs EMR vs IR vs AME
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
LECO vs PH vs EMR vs IR vs AME — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Manufacturing - Tools & Accessories | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $14.86B | $110.92B | $79.14B | $29.67B | $53.23B |
| Revenue (TTM) | $4.35B | $20.99B | $18.32B | $7.78B | $7.60B |
| Net Income (TTM) | $538M | $3.48B | $2.44B | $587M | $1.53B |
| Gross Margin | 36.1% | 37.2% | 52.7% | 38.2% | 36.6% |
| Operating Margin | 17.1% | 20.9% | 19.8% | 18.1% | 26.2% |
| Forward P/E | 24.7x | 28.2x | 21.7x | 21.6x | 28.6x |
| Total Debt | $1.29B | $9.64B | $13.76B | $4.78B | $2.28B |
| Cash & Equiv. | $309M | $467M | $1.54B | $1.25B | $458M |
LECO vs PH vs EMR vs IR vs AME — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Lincoln Electric Ho… (LECO) | 100 | 329.9 | +229.9% |
| Parker-Hannifin Cor… (PH) | 100 | 488.3 | +388.3% |
| Emerson Electric Co. (EMR) | 100 | 231.5 | +131.5% |
| Ingersoll Rand Inc. (IR) | 100 | 268.6 | +168.6% |
| AMETEK, Inc. (AME) | 100 | 253.4 | +153.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LECO vs PH vs EMR vs IR vs AME
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LECO is the #2 pick in this set and the best alternative if valuation efficiency and defensive is your priority.
- PEG 1.11 vs EMR's 4.80
- Beta 1.12, yield 1.1%, current ratio 1.82x
- +46.5% vs IR's -4.3%
- 14.2% ROA vs IR's 3.2%, ROIC 22.7% vs 7.8%
PH is the clearest fit if your priority is long-term compounding.
- 7.3% 10Y total return vs AME's 418.8%
EMR ranks third and is worth considering specifically for income & stability.
- Dividend streak 37 yrs, beta 1.57, yield 1.5%
- 1.5% yield, 37-year raise streak, vs PH's 0.8%
IR is the clearest fit if your priority is value.
- Lower P/E (21.6x vs 28.6x)
AME carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 6.6%, EPS growth 7.9%, 3Y rev CAGR 6.4%
- Lower volatility, beta 0.94, Low D/E 21.5%, current ratio 1.06x
- 6.6% revenue growth vs PH's -0.4%
- 20.1% margin vs IR's 7.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.6% revenue growth vs PH's -0.4% | |
| Value | Lower P/E (21.6x vs 28.6x) | |
| Quality / Margins | 20.1% margin vs IR's 7.5% | |
| Stability / Safety | Beta 0.94 vs EMR's 1.57, lower leverage | |
| Dividends | 1.5% yield, 37-year raise streak, vs PH's 0.8% | |
| Momentum (1Y) | +46.5% vs IR's -4.3% | |
| Efficiency (ROA) | 14.2% ROA vs IR's 3.2%, ROIC 22.7% vs 7.8% |
LECO vs PH vs EMR vs IR vs AME — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
LECO vs PH vs EMR vs IR vs AME — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AME leads in 2 of 6 categories
IR leads 1 • LECO leads 1 • PH leads 1 • EMR leads 1
Explore the data ↓Income & Cash Flow (Last 12 Months)
AME leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PH is the larger business by revenue, generating $21.0B annually — 4.8x LECO's $4.3B. AME is the more profitable business, keeping 20.1% of every revenue dollar as net income compared to IR's 7.5%. On growth, LECO holds the edge at +11.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.3B | $21.0B | $18.3B | $7.8B | $7.6B |
| EBITDAEarnings before interest/tax | $845M | $5.1B | $4.7B | $1.9B | $2.3B |
| Net IncomeAfter-tax profit | $538M | $3.5B | $2.4B | $587M | $1.5B |
| Free Cash FlowCash after capex | $438M | $3.7B | $3.1B | $1.2B | $1.7B |
| Gross MarginGross profit ÷ Revenue | +36.1% | +37.2% | +52.7% | +38.2% | +36.6% |
| Operating MarginEBIT ÷ Revenue | +17.1% | +20.9% | +19.8% | +18.1% | +26.2% |
| Net MarginNet income ÷ Revenue | +12.4% | +16.6% | +13.3% | +7.5% | +20.1% |
| FCF MarginFCF ÷ Revenue | +10.1% | +17.5% | +17.0% | +14.9% | +22.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.6% | +10.6% | +2.9% | +7.6% | +11.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +17.6% | -4.2% | +28.2% | +6.5% | +14.5% |
Valuation Metrics
IR leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 29.1x trailing earnings, LECO trades at a 44% valuation discount to IR's 52.2x P/E. Adjusting for growth (PEG ratio), LECO offers better value at 1.31x vs EMR's 7.74x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $14.9B | $110.9B | $79.1B | $29.7B | $53.2B |
| Enterprise ValueMkt cap + debt − cash | $15.8B | $120.1B | $91.4B | $33.2B | $55.1B |
| Trailing P/EPrice ÷ TTM EPS | 29.09x | 32.41x | 34.97x | 52.24x | 36.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.71x | 28.15x | 21.70x | 21.57x | 28.56x |
| PEG RatioP/E ÷ EPS growth rate | 1.31x | 1.36x | 7.74x | — | 3.25x |
| EV / EBITDAEnterprise value multiple | 19.48x | 24.18x | 18.09x | 17.26x | 29.29x |
| Price / SalesMarket cap ÷ Revenue | 3.51x | 5.59x | 4.39x | 3.88x | 7.19x |
| Price / BookPrice ÷ Book value/share | 10.31x | 8.36x | 3.94x | 2.99x | 5.06x |
| Price / FCFMarket cap ÷ FCF | 27.82x | 33.20x | 29.67x | 24.31x | 31.85x |
Profitability & Efficiency
LECO leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
LECO delivers a 37.3% return on equity — every $100 of shareholder capital generates $37 in annual profit, vs $6 for IR. AME carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to LECO's 0.88x. On the Piotroski fundamental quality scale (0–9), PH scores 8/9 vs IR's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +37.3% | +24.3% | +12.1% | +5.8% | +14.4% |
| ROA (TTM)Return on assets | +14.2% | +11.5% | +5.8% | +3.2% | +9.6% |
| ROICReturn on invested capital | +22.7% | +13.4% | +8.2% | +7.8% | +12.1% |
| ROCEReturn on capital employed | +26.2% | +17.8% | +10.0% | +8.7% | +15.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 | 7 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.88x | 0.70x | 0.68x | 0.47x | 0.21x |
| Net DebtTotal debt minus cash | $985M | $9.2B | $12.2B | $3.5B | $1.8B |
| Cash & Equiv.Liquid assets | $309M | $467M | $1.5B | $1.2B | $458M |
| Total DebtShort + long-term debt | $1.3B | $9.6B | $13.8B | $4.8B | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | 12.38x | 11.39x | 6.46x | 4.53x | 23.34x |
Total Returns (Dividends Reinvested)
PH leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PH five years ago would be worth $28,733 today (with dividends reinvested), compared to $15,186 for IR. Over the past 12 months, LECO leads with a +46.5% total return vs IR's -4.3%. The 3-year compound annual growth rate (CAGR) favors PH at 39.1% vs IR's 8.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +11.5% | -1.3% | +4.4% | -5.0% | +11.3% |
| 1-Year ReturnPast 12 months | +46.5% | +38.4% | +27.7% | -4.3% | +36.2% |
| 3-Year ReturnCumulative with dividends | +65.1% | +168.9% | +76.2% | +28.9% | +62.6% |
| 5-Year ReturnCumulative with dividends | +110.8% | +187.3% | +59.1% | +51.9% | +73.3% |
| 10-Year ReturnCumulative with dividends | +389.7% | +732.6% | +207.0% | +291.2% | +418.8% |
| CAGR (3Y)Annualised 3-year return | +18.2% | +39.1% | +20.8% | +8.8% | +17.6% |
Risk & Volatility
AME leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AME is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than EMR's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AME currently trades 95.6% from its 52-week high vs IR's 75.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 1.00x | 1.57x | 1.50x | 0.94x |
| 52-Week HighHighest price in past year | $310.00 | $1034.96 | $165.15 | $100.96 | $243.18 |
| 52-Week LowLowest price in past year | $181.90 | $628.23 | $109.53 | $72.45 | $170.47 |
| % of 52W HighCurrent price vs 52-week peak | +87.5% | +84.9% | +85.6% | +75.0% | +95.6% |
| RSI (14)Momentum oscillator 0–100 | 59.2 | 39.5 | 51.4 | 41.2 | 54.5 |
| Avg Volume (50D)Average daily shares traded | 347K | 713K | 2.8M | 3.1M | 1.2M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: LECO as "Hold", PH as "Buy", EMR as "Buy", IR as "Buy", AME as "Buy". Consensus price targets imply 31.4% upside for IR (target: $100) vs 6.6% for AME (target: $248). For income investors, EMR offers the higher dividend yield at 1.49% vs IR's 0.10%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $301.71 | $1042.08 | $161.31 | $99.50 | $247.73 |
| # AnalystsCovering analysts | 22 | 38 | 41 | 15 | 29 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | +0.8% | +1.5% | +0.1% | +0.5% |
| Dividend StreakConsecutive years of raises | 12 | 33 | 37 | 0 | 16 |
| Dividend / ShareAnnual DPS | $3.01 | $6.61 | $2.10 | $0.08 | $1.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.3% | +1.6% | +1.6% | +3.4% | +0.8% |
AME leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). IR leads in 1 (Valuation Metrics).
LECO vs PH vs EMR vs IR vs AME: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is LECO or PH or EMR or IR or AME a better buy right now?
For growth investors, AMETEK, Inc.
(AME) is the stronger pick with 6. 6% revenue growth year-over-year, versus -0. 4% for Parker-Hannifin Corporation (PH). Lincoln Electric Holdings, Inc. (LECO) offers the better valuation at 29. 1x trailing P/E (24. 7x forward), making it the more compelling value choice. Analysts rate Parker-Hannifin Corporation (PH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LECO or PH or EMR or IR or AME?
On trailing P/E, Lincoln Electric Holdings, Inc.
(LECO) is the cheapest at 29. 1x versus Ingersoll Rand Inc. at 52. 2x. On forward P/E, Ingersoll Rand Inc. is actually cheaper at 21. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Lincoln Electric Holdings, Inc. wins at 1. 11x versus Emerson Electric Co. 's 4. 80x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — LECO or PH or EMR or IR or AME?
Over the past 5 years, Parker-Hannifin Corporation (PH) delivered a total return of +187.
3%, compared to +51. 9% for Ingersoll Rand Inc. (IR). Over 10 years, the gap is even starker: PH returned +732. 6% versus EMR's +207. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LECO or PH or EMR or IR or AME?
By beta (market sensitivity over 5 years), AMETEK, Inc.
(AME) is the lower-risk stock at 0. 94β versus Emerson Electric Co. 's 1. 57β — meaning EMR is approximately 67% more volatile than AME relative to the S&P 500. On balance sheet safety, AMETEK, Inc. (AME) carries a lower debt/equity ratio of 21% versus 88% for Lincoln Electric Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — LECO or PH or EMR or IR or AME?
By revenue growth (latest reported year), AMETEK, Inc.
(AME) is pulling ahead at 6. 6% versus -0. 4% for Parker-Hannifin Corporation (PH). On earnings-per-share growth, the picture is similar: Parker-Hannifin Corporation grew EPS 24. 2% year-over-year, compared to -29. 6% for Ingersoll Rand Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LECO or PH or EMR or IR or AME?
AMETEK, Inc.
(AME) is the more profitable company, earning 20. 0% net margin versus 7. 6% for Ingersoll Rand Inc. — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AME leads at 26. 2% versus 16. 9% for LECO. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LECO or PH or EMR or IR or AME more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Lincoln Electric Holdings, Inc. (LECO) is the more undervalued stock at a PEG of 1. 11x versus Emerson Electric Co. 's 4. 80x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Ingersoll Rand Inc. (IR) trades at 21. 6x forward P/E versus 28. 6x for AMETEK, Inc. — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IR: 31. 4% to $99. 50.
08Which pays a better dividend — LECO or PH or EMR or IR or AME?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 1% for Ingersoll Rand Inc. (IR).
09Is LECO or PH or EMR or IR or AME better for a retirement portfolio?
For long-horizon retirement investors, Parker-Hannifin Corporation (PH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
00), 0. 8% yield, +732. 6% 10Y return). Ingersoll Rand Inc. (IR) carries a higher beta of 1. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PH: +732. 6%, IR: +291. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LECO and PH and EMR and IR and AME?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
LECO, PH, EMR, AME pay a dividend while IR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.